Systems Biology Resources Arising from the Human Metabolome Project

Chapter

Abstract

This chapter provides an overview of a number of the on-line, open-access databases that have arisen from the Human Metabolome Project (HMP). It is primarily intended to show how these resources can be used to easily link genetic, proteomic or physiological data to human metabolomic data. The HMP was started in 2005 and continues to this day. It was mandated to use advanced experimental methods along with literature/data mining to quantitatively characterize and describe as many human metabolites in common biofluids and tissues as possible. The HMP was also tasked with linking this metabolomic information to diseases, mechanisms, genes/proteins and pathways. These data sets have been made public through a variety of on-line, continuously updated databases including the Human Metabolome Database (HMDB), DrugBank, the Toxin, Toxin-Target Database (T3DB), FooDB and the Small Molecule Pathway Database (SMPDB). The integration of such a large quantity of proteomic, genomic and metabolomic data on humans has made these resources particular valuable for wide ranging applications from systems biology to medicine.

Keywords

Adduct Alkaloid Microbe Quinone Pyramid 

References

  1. 1.
    Jakobs C, Schweitzer S, Dorland B (1995) Galactitol in galactosemia. Eur J Pediatr 154:S50–S52PubMedCrossRefGoogle Scholar
  2. 2.
    Bory C, Boulieu R, Chantin C, Mathieu M (1990) Diagnosis of alcaptonuria: rapid analysis of homogentisic acid by HPLC. Clin Chim Acta 189:7–11PubMedCrossRefGoogle Scholar
  3. 3.
    Kornberg H (2000) Krebs and his trinity of cycles. Nat Rev Mol Cell Biol 1:225–228PubMedCrossRefGoogle Scholar
  4. 4.
    Kohler R (1982) From medical chemistry to biochemistry: the making of a biomedical discipline. Cambridge University Press, CambridgeCrossRefGoogle Scholar
  5. 5.
    German JB, Hammock BD, Watkins SM (2005) Metabolomics: building on a century of biochemistry to guide human health. Metabolomics 1:3–9PubMedCrossRefGoogle Scholar
  6. 6.
    Tietz NW (1995) Clinical guide to laboratory tests, 3rd edn. WB Saunders Press, PhiladelphiaGoogle Scholar
  7. 7.
    Wishart DS (2008) Metabolomics: applications to food science and nutrition research. Trends Food Sci Technol 19:482–493CrossRefGoogle Scholar
  8. 8.
    Mahido C, Ruchirawat S, Prawat H et al (1998) Pure Appl Chem 70:2065–2072CrossRefGoogle Scholar
  9. 9.
    Hamosh A, Scott AF, Amberger J et al (2002) Online mendelian inheritance in man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 30:52–55PubMedCrossRefGoogle Scholar
  10. 10.
    Katzmarzyk PT, Janssen I (2004) The economic costs associated with physical inactivity and obesity. Can J Appl Physiol 29:90–115PubMedCrossRefGoogle Scholar
  11. 11.
    Johnson JA, Pohar SL, Majumdar SR (2006) Health care use and costs in the decade after identification of type 1 and type 2 diabetes: a population-based study. Diabetes Care 29:2403–2408PubMedCrossRefGoogle Scholar
  12. 12.
    Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279:1200–1205PubMedCrossRefGoogle Scholar
  13. 13.
    Koren G (1993) Preconceptional folate and neural tube defects: time for rethinking. Can J Public Health 84:207–208PubMedGoogle Scholar
  14. 14.
    French AE, Grant R, Weitzman S et al (2003) Folic acid food fortification is associated with a decline in neuroblastoma. Clin Pharmacol Ther 74:288–294PubMedCrossRefGoogle Scholar
  15. 15.
    Verster A (2004) Food fortification: good to have or need to have? East Mediterr Health J 10:771–777PubMedGoogle Scholar
  16. 16.
    Venter JC, Adams MD, Meyers EW et al (2001) The sequence of the human genome. Science 291:1304–1351PubMedCrossRefGoogle Scholar
  17. 17.
    HUPO (2010) A gene-centric human proteome project: HUPO–the Human Proteome organization. Mol Cell Proteomics 9:427–429CrossRefGoogle Scholar
  18. 18.
    Hodgkin AL, Huxley AF (1952) A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol 117:500–544PubMedGoogle Scholar
  19. 19.
    Wishart DS (2007) Proteomics and the human metabolome project. Expert Rev Proteomics 4:333–335PubMedCrossRefGoogle Scholar
  20. 20.
    Wishart DS, Knox C, Guo AC et al (2009) HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 37:D603–D610PubMedCrossRefGoogle Scholar
  21. 21.
    Knox C, Law V, Jewison T et al (2011) DrugBank 3.0: a comprehensive resource for ‘omics’ research on drugs. Nucleic Acids Res 39:D1035–D1041PubMedCrossRefGoogle Scholar
  22. 22.
    Lim E, Pon A, Djoumbou Y et al (2010) T3DB: a comprehensively annotated database of common toxins and their targets. Nucleic Acids Res 38:D781–D786PubMedCrossRefGoogle Scholar
  23. 23.
    Scalbert A, Andres-Lacueva C, Arita M et al (2011) Databases on food phytochemicals and their health-promoting effects. J Agric Food Chem 59:4331–4348Google Scholar
  24. 24.
    Wishart DS, Lewis MJ, Morrissey JA et al (2008) The human cerebrospinal fluid metabolome. J Chromatogr B Analyt Technol Biomed Life Sci 871:164–173PubMedCrossRefGoogle Scholar
  25. 25.
    Guo K, Bamforth F, Li L (2011) Qualitative metabolome analysis of human cerebrospinal fluid by (13)c-/(12)c-isotope dansylation labeling combined with liquid chromatography fourier transform ion cyclotron resonance mass spectrometry. J Am Soc Mass Spectrom 22:339–347PubMedCrossRefGoogle Scholar
  26. 26.
    Psychogios N, Hau DD, Peng J et al (2011) The human serum metabolome. PLoS One 6:e16957PubMedCrossRefGoogle Scholar
  27. 27.
    Guo K, Li L (2009) Differential 12 C-/13 C-isotope dansylation labeling and fast liquid chromatography/mass spectrometry for absolute and relative quantification of the metabolome. Anal Chem 81:3919–3932PubMedCrossRefGoogle Scholar
  28. 28.
    Eckburg PB, Bik EM, Bernstein CN et al (2005) Diversity of the human intestinal microbial flora. Science 308:1635–1638PubMedCrossRefGoogle Scholar
  29. 29.
    Holmes E, Wilson ID, Nicholson JK (2008) Metabolic phenotyping in health and disease. Cell 134:714–717PubMedCrossRefGoogle Scholar
  30. 30.
    Slupsky CM, Rankin KN, Wagner J et al (2007) Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal Chem 79:6995–7004PubMedCrossRefGoogle Scholar
  31. 31.
    Bou Khalil M, Hou W, Zhou H et al (2010) Lipidomics era: accomplishments and challenges. Mass Spectrom Rev 29:877–929PubMedCrossRefGoogle Scholar
  32. 32.
    Smith CA, O’Maille G, Want EJ et al (2005) METLIN: a metabolite mass spectral database. Ther Drug Monit 27:747–751PubMedCrossRefGoogle Scholar
  33. 33.
    Wishart DS (2009) Computational strategies for metabolite identification in metabolomics. Bioanalysis 1:1579–1596PubMedCrossRefGoogle Scholar
  34. 34.
    Kanehisa M, Goto S, Hattori M et al (2006) From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 34:D354–D357PubMedCrossRefGoogle Scholar
  35. 35.
    Krummenacker M, Paley S, Mueller L et al (2005) Querying and computing with BioCyc databases. Bioinformatics 21:3454–3455PubMedCrossRefGoogle Scholar
  36. 36.
    Wang Y, Xiao J, Suzek TO et al (2009) PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res 37:W623–W633PubMedCrossRefGoogle Scholar
  37. 37.
    Degtyarenko K, de Matos P, Ennis M et al (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res 36:D344–D350PubMedCrossRefGoogle Scholar
  38. 38.
    Westbrook J, Feng Z, Jain S et al (2002) The protein data bank: unifying the archive. Nucleic Acids Res 30:245–248PubMedCrossRefGoogle Scholar
  39. 39.
    Boutet E, Lieberherr D, Tognolli M et al (2007) UniProtKB/Swiss-Prot. Methods Mol Biol 406:89–112PubMedGoogle Scholar
  40. 40.
    Benson DA, Karsch-Mizrachi I, Lipman DJ et al (2010) GenBank. Nucleic Acids Res 38:D46–D51PubMedCrossRefGoogle Scholar
  41. 41.
    Wishart DS (2008) Applications of metabolomics in drug discovery and development. Drugs R&D 9:307–322CrossRefGoogle Scholar
  42. 42.
    Wishart DS, Knox C, Guo AC et al (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 36:D901–D906PubMedCrossRefGoogle Scholar
  43. 43.
    Sumner L, Amberg A, Barrett D et al (2007) Proposed minimum reporting standards for chemical analysis. Metabolomics 3:211–221CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of Computing Science and Biological SciencesUniversity of AlbertaEdmontonCanada

Personalised recommendations